What are the uses and dosing guidelines for ketamine in medical settings, including anesthesia and pain management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ketamine: Clinical Uses and Dosing Guidelines

Primary Medical Applications

Ketamine serves three FDA-approved and guideline-supported roles: general anesthesia induction and maintenance, acute perioperative pain management as an opioid-sparing agent, and treatment-resistant depression (esketamine formulation). 1

Anesthesia

  • Induction dosing: 1-4.5 mg/kg IV (average 2 mg/kg produces 5-10 minutes of surgical anesthesia within 30 seconds) or 9-13 mg/kg IM (produces surgical anesthesia within 3-4 minutes lasting 12-25 minutes) 1
  • Maintenance: Repeat half to full induction dose as needed, or continuous infusion at 0.1-0.5 mg/minute 1
  • Administer IV doses slowly over 60 seconds to prevent respiratory depression and enhanced vasopressor response 1
  • Critical advantage: Maintains cardiovascular stability through central NMDA blockade and preserved adrenal function, making it superior to propofol or dexmedetomidine in shock states 2, 3
  • Produces bronchodilation, making it the agent of choice for patients with life-threatening asthma or acute bronchial constriction 4

Acute Pain Management

For perioperative pain, use sub-anesthetic doses of 0.5 mg/kg IV bolus followed by 1-2 μg/kg/min infusion, which reduces opioid requirements by approximately 22 mg morphine equivalents without increasing side effects. 2

Specific Dosing Protocols:

  • Intraoperative: Maximum 0.5 mg/kg/h after anesthesia induction, with continuous infusion at 0.125-0.25 mg/kg/h; discontinue 30 minutes before end of surgery and administer longer-acting opioid to prevent analgesic gap 2, 5
  • ICU setting: 0.5-2 mg/kg/hr continuous infusion (maximum 100 mg/hour), using lowest effective dose 2
  • Pediatric patients: 0.5 mg/kg as adjunct to intraoperative opioids, with optional continuous infusion of 0.1-0.2 mg/kg/hr (maximum 0.4 mg/kg/hr) 2
  • Breakthrough pain in PACU: 0.5 mg/kg titrated to effect 2

Route-Specific Efficacy:

  • Local infiltration (particularly peritonsillar) consistently demonstrates superior analgesia compared to IV administration and effectively reduces pain and analgesic requirements 6
  • Subcutaneous administration provides similar analgesia to IV route 6
  • Intramuscular route lacks analgesic efficacy 6
  • Oral administration is less effective than infiltration 6

Specialized Pain Applications

  • Cancer-related neuropathic pain: IV ketamine recommended when other modalities fail, though data suggest only modest analgesic potential for opioid-refractory cancer pain 2
  • ICU patients with refractory pain: Ketamine helps prevent or reduce opioid tolerance and provides relief when pain is unresponsive to opioids and other agents 6
  • Pre-operative administration provides better pain relief than postoperative dosing 6

Critical Safety Considerations

Monitoring Requirements

When administering ketamine for procedural sedation, provide care consistent with general anesthesia standards, including ability to identify and rescue patients from unintended deep sedation. 5

  • Maintain vascular access throughout procedure until patient is no longer at risk for cardiorespiratory depression 5
  • Continuous cardiac monitoring and pulse oximetry during infusion 2
  • Regular assessment of sedation level, respiratory status, and hemodynamics 2, 5

Side Effects Management

  • Emergence reactions (postoperative confusional states, agitation, vivid imagery, hallucinations) occur in approximately 12% of patients 1
  • Psychotomimetic effects (dysphoria, nightmares, hallucinations) occur especially at higher doses; co-administration with benzodiazepines minimizes these effects 6, 2, 1
  • Administer benzodiazepine during induction and maintenance to prevent neuropsychological manifestations during emergence 1
  • Minimize verbal, tactile, and visual stimulation during recovery period 1
  • Sedation was the predominant side effect in multiple studies 6
  • Continuation of ketamine into postoperative period increases hallucination risk without significantly enhancing analgesia 5

Absolute Contraindications

  • Uncontrolled cardiovascular disease (contraindicated when significant blood pressure elevation would constitute serious hazard) 2, 5, 1
  • Pregnancy 2, 5
  • Active psychosis 5
  • Severe liver dysfunction 5
  • High intracranial or ocular pressure 5
  • Known hypersensitivity to ketamine or excipients 1

Special Populations

Patients with Hemodynamic Instability

  • Ketamine maintains cardiovascular stability better than alternatives, but can still suppress myocardial contractility in patients with depleted catecholamine reserves 3
  • Start at lower end of dosing range (0.5 mg/kg IV bolus) and titrate carefully in significant hemodynamic compromise 3
  • Monitor for transient increases in blood pressure, heart rate, and cardiac index, as well as potential decreases in blood pressure, arrhythmias, and cardiac decompensation 1

Pediatric Procedural Sedation

  • Combination of ketamine and midazolam shows fewer complications compared to midazolam/meperidine regimens 5
  • 88% of pediatric patients successfully sedated at initial doses of 1 mg/kg or less 5

Preparation and Administration

  • Do not inject 100 mg/mL concentration IV without proper dilution 1
  • For induction: Dilute with equal volume of Sterile Water, Normal Saline, or 5% Dextrose; use immediately after dilution 1
  • For maintenance infusion: Add 10 mL from 50 mg/mL vial or 5 mL from 100 mg/mL vial to 500 mL of 5% Dextrose or Normal Saline to create 1 mg/mL solution 1
  • When fluid restriction required: Add to 250 mL infusion to provide 2 mg/mL concentration 1
  • Inspect for particulate matter and discoloration before administration; discard if present 1

Key Clinical Pearls

  • Avoid mixed agonist-antagonists (butorphanol, pentazocine) in combination with ketamine 2
  • Strong evidence supports IV ketamine in perioperative period to reduce opioid use in first 24 hours after hip and knee arthroplasty 5
  • Purposeless and tonic-clonic movements of extremities may occur during ketamine anesthesia; these do not indicate light anesthesia plane or need for additional doses 1
  • Ketamine provides analgesia while reducing opioid requirements, potentially beneficial in patients with gastritis at risk for opioid-induced gastrointestinal side effects 3

References

Guideline

Ketamine for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ketamine for Pain Management in Patients with Shock and Gastritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guidelines for Safe Administration of Ketamine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.